GE HealthCare reports Q3 2026 results and raises full-year guidance
FROM THE WIRE · FINANCE.YAHOO.COM
Delivers top- and bottom-line growth ahead of Company expectations and raises full-year 2026 guidance Revenue growth of 7.2%, and Organic revenue growth* of 6.2% Organic orders growth of 4.0%, book-to-bill of 1.03 times and backlog of $23.7 billion Net income margin of 11.1% and…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishThe release confirms growth ahead of expectations and higher full-year guidance, relevant for the stock.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Revenue grew 7.2% and organic revenue grew 6.2%.
- 02Organic orders grew 4.0%, with a book-to-bill of 1.03 and backlog of $23.7 billion.
- 03Diluted EPS of $1.36 grew 39.1%, while adjusted EPS of $1.34 grew 25.1%.
- 04Free cash flow was $793 million for the quarter.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets